Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

収録刊行物

• Mol Cancer Ther.

  Mol Cancer Ther. 2 971-984, 2003